Below are the most recent publications written about "Adenocarcinoma, Papillary" by people in Profiles.
-
Skaznik-Wikiel ME, Lesnock JL, McBee WC, Beriwal S, Zorn KK, Richard SD, Krivak TC, Edwards RP. Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes. Int J Gynecol Cancer. 2012 Feb; 22(2):232-7.
-
Skaznik-Wikiel ME, Sukumvanich P, Beriwal S, Zorn KK, Kelley JL, Richard SD, Krivak TC. Possible use of CA-125 level normalization after the third chemotherapy cycle in deciding on chemotherapy regimen in patients with epithelial ovarian cancer: brief report. Int J Gynecol Cancer. 2011 Aug; 21(6):1013-7.
-
Adler JT, Chen H, Schaefer S, Sippel RS. Does routine use of ultrasound result in additional thyroid procedures in patients with primary hyperparathyroidism? J Am Coll Surg. 2010 Oct; 211(4):536-9.
-
Bickenbach K, Galka E, Roggin KK. Molecular mechanisms of cholangiocarcinogenesis: are biliary intraepithelial neoplasia and intraductal papillary neoplasms of the bile duct precursors to cholangiocarcinoma? Surg Oncol Clin N Am. 2009 Apr; 18(2):215-24, vii.
-
O'Kane P, Shelkovoy E, McConnell RJ, Shpak V, Parker L, Bogdanova TI, Brenner A, Naida Y, Frangos A, Zablotska L, Robbins J, Greenebaum E, Zurnadzhy LY, Tronko M, Hatch M. Differences in sonographic conspicuity according to papillary thyroid cancer subtype: results of the Ukrainian-American cohort study after the Chornobyl accident. AJR Am J Roentgenol. 2008 Dec; 191(6):W293-8.
-
Brody JR, Witkiewicz A, Williams TK, Kadkol SS, Cozzitorto J, Durkan B, Pasternack GR, Yeo CJ. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia. Mod Pathol. 2007 Dec; 20(12):1238-44.
-
Lyshchik A, Higashi T, Asato R, Tanaka S, Ito J, Hiraoka M, Insana MF, Brill AB, Saga T, Togashi K. Cervical lymph node metastases: diagnosis at sonoelastography--initial experience. Radiology. 2007 Apr; 243(1):258-67.
-
Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y, DeMatteo RP, D'Angelica M, Koea J, Blumgart LH. Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005 May; 241(5):703-12; discussion 712-4.
-
Sato N, Fukushima N, Maitra A, Iacobuzio-Donahue CA, van Heek NT, Cameron JL, Yeo CJ, Hruban RH, Goggins M. Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am J Pathol. 2004 Mar; 164(3):903-14.
-
Householder J, Han A, Edelson MI, Eager JM, Rosenblum NG. Immunohistochemical confirmation of pulmonary papillary adenocarcinoma metastatic to ovaries. Arch Pathol Lab Med. 2002 Sep; 126(9):1101-3.